FDA’s Full Pfizer Approval Fuels a Risk-On Rally

Growth stocks and related exchange traded funds rallied Monday as investors shifted to a risk-on mood in response to the U.S. drug regulator granting full approval for Pfizer-BioNtech’s Covid-19 vaccine. The U.S. Food and Drug Administration has fully approved the Pfizer Inc/BioNTech SE...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.